Rare diseases
Investigational molecules
Locations
Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
PolandBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
PolandFaricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia
PolandComparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes
PolandPhase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression
PolandA study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema
PolandA study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa
PolandA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
PolandStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
PolandA Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa
PolandComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
PolandPhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
